IDEXX Laboratories, Inc. (IDXX) Tops Q1 EPS by 2c; Increases FY11 EPS Outlook
Get Alerts IDXX Hot Sheet
Price: $553.48 -0.8%
Revenue Growth %: +8.2%
Financial Fact:
Income before provision for income taxes: 81.52M
Today's EPS Names:
FNLC, LSBK, OVLY, More
Revenue Growth %: +8.2%
Financial Fact:
Income before provision for income taxes: 81.52M
Today's EPS Names:
FNLC, LSBK, OVLY, More
Join SI Premium – FREE
IDEXX Laboratories, Inc. (NASDAQ: IDXX) reported Q1 EPS of $0.62, $0.02 better than the analyst estimate of $0.60. Revenue for the quarter came in at $292.7 million versus the consensus estimate of $285.61 million.
Increases FY11 EPS outlook from $2.62 - $2.68 to $2.66 - $2.71, versus the consensus of $2.66. Also sees FY11 revenue of $1.205 - $1.215 billion, versus the consensus of $1.19 billion.
Increases FY11 EPS outlook from $2.62 - $2.68 to $2.66 - $2.71, versus the consensus of $2.66. Also sees FY11 revenue of $1.205 - $1.215 billion, versus the consensus of $1.19 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Integra LifeSciences (IART) Tops Q3 EPS by 3c; offers guidance
- Jefferies downgrades Zoetis, Elanco on pricing risk; prefers IDEXX
- Medpace Holdings (MEDP) Tops Q3 EPS by 40c; offers guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share